• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by .伴有类Rosai-Dorfman病变的Erdheim-Chester病：一种主要由……驱动的独特实体
Haematologica. 2020 Jan;105(1):e5-e8. doi: 10.3324/haematol.2019.216937. Epub 2019 May 23.
2
MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.MAP2K1 驱动的朗格汉斯细胞组织细胞增生症、罗道尔夫-多布姆病和埃勒-当斯伯格病与急性髓系白血病克隆相关。
J Cutan Pathol. 2021 May;48(5):637-643. doi: 10.1111/cup.13918. Epub 2020 Nov 24.
3
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.罗道尔夫病中相互排斥的 KRAS 和 MAP2K1 突变。
Mod Pathol. 2017 Oct;30(10):1367-1377. doi: 10.1038/modpathol.2017.55. Epub 2017 Jun 30.
4
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.厄德海姆-切斯特病伴罗萨达-多夫曼样病变：甲氨蝶呤、阿那白滞素和乌帕替尼治疗。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002852.
5
Erdheim-Chester Disease: A Case Report of BRAF V600E-Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review.额颞叶痴呆病：BRAF V600E 阴性、MAP2K1 阳性 ECD 病例报告，采用血液下一代测序检测诊断，并进行简要文献复习。
Oncology (Williston Park). 2023 Jul 21;37(7):298-302. doi: 10.46883/2023.25921001.
6
Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.MEK抑制剂考比替尼治疗野生型BRAF Erdheim-Chester病的疗效。
Br J Haematol. 2018 Jan;180(1):150-153. doi: 10.1111/bjh.14284. Epub 2016 Oct 6.
7
Erdheim-Chester disease: description of two illustrative cases involving the lung.厄德海姆-切斯特病：两例累及肺部的病例描述。
Histopathology. 2018 Jul;73(1):167-172. doi: 10.1111/his.13501. Epub 2018 Apr 19.
8
[Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].[ Erdheim-Chester病：一种非朗格汉斯细胞组织细胞增多症。1例临床病例及文献复习]
Clin Ter. 2004 May;155(5):205-8.
9
Erdheim-Chester disease mimicking an intracranial trigeminal schwannoma: case report.酷似颅内三叉神经鞘瘤的 Erdheim-Chester 病：病例报告
J Neurosurg Pediatr. 2015 May;15(5):493-8. doi: 10.3171/2014.10.PEDS14441. Epub 2015 Feb 27.
10
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.MAP2K1和BRAF中相互排斥的复发性体细胞突变支持ERK激活在朗格汉斯细胞组织细胞增生症（LCH）发病机制中起核心作用。
Blood. 2014 Nov 6;124(19):3007-15. doi: 10.1182/blood-2014-05-577825. Epub 2014 Sep 8.

引用本文的文献

1
Head and neck hematolymphoid proliferations: what is new?头颈部血液淋巴组织增生：有哪些新进展？
Pathologica. 2025 Apr;117(2):101-110. doi: 10.32074/1591-951X-1207.
2
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.聚类分析揭示了 Erdheim-Chester 病的临床谱。
Leukemia. 2025 May 28. doi: 10.1038/s41375-025-02656-w.
3
Extensive Bone Marrow Involvement by -Mutated Bi-Phenotypic Erdheim-Chester Neoplasm/Rosai-Dorfman Disease (Mixed Histiocytic Neoplasm) with Atypical Histological Features and Fulminant Hemophagocytosis.具有非典型组织学特征和暴发性噬血细胞作用的BRAF基因变异双表型 Erdheim-Chester 肿瘤/罗萨伊-多夫曼病（混合组织细胞肿瘤）的广泛骨髓受累。
Case Rep Oncol. 2025 May 26;18(1):602-612. doi: 10.1159/000545775. eCollection 2025 Jan-Dec.
4
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.NTRK1重排组织细胞增多症：临床病理及分子特征
Blood Adv. 2025 Jul 22;9(14):3617-3628. doi: 10.1182/bloodadvances.2025016167.
5
IgG4-related disease and other fibro-inflammatory conditions.IgG4相关性疾病及其他纤维炎性疾病。
Nat Rev Rheumatol. 2025 May;21(5):275-290. doi: 10.1038/s41584-025-01240-x. Epub 2025 Apr 7.
6
Recent advances in therapeutic strategies of Erdheim-Chester disease.Erdheim-Chester病治疗策略的最新进展
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6407-6428. doi: 10.1007/s00210-024-03769-2. Epub 2025 Jan 21.
7
Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder.患者诊疗方法：从内分泌病到组织细胞疾病的诊断
J Clin Endocrinol Metab. 2025 May 19;110(6):1756-1766. doi: 10.1210/clinem/dgae827.
8
BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature.罗萨伊-多夫曼病中BRAF V600E突变与程序性死亡配体1（PD-L1）的高表达：病例报告及文献复习
J Hematop. 2024 Dec;17(4):183-189. doi: 10.1007/s12308-024-00611-9. Epub 2024 Nov 27.
9
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms.不确定的树突细胞组织细胞增生症有别于朗格汉斯细胞组织细胞增生症，且常与其他造血肿瘤相关。
Blood Adv. 2024 Nov 26;8(22):5796-5805. doi: 10.1182/bloodadvances.2024013545.
10
Rosai-Dorfman-Destombes disease in adults: a single center experience.成人 Rosai-Dorfman-Destombes 病：单中心经验。
Ann Hematol. 2024 Nov;103(11):4467-4476. doi: 10.1007/s00277-024-06019-w. Epub 2024 Sep 27.

本文引用的文献

1
V600E mutation detected in a case of Rosai-Dorfman disease.在一例Rosai-Dorfman病患者中检测到V600E突变。
Haematologica. 2018 Aug;103(8):e377-e379. doi: 10.3324/haematol.2018.190934. Epub 2018 May 10.
2
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.罗萨-多夫曼-德斯东贝病的诊断和临床管理共识建议。
Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2.
3
[Rosai-Dorfman disease: Diagnosis and therapeutic challenges].[罗萨伊-多夫曼病：诊断与治疗挑战]
Rev Med Interne. 2018 Aug;39(8):635-640. doi: 10.1016/j.revmed.2018.02.011. Epub 2018 Mar 1.
4
Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.厄尔德海姆-切斯特病的表型与生存情况：来自165例患者队列的结果
Am J Hematol. 2018 May;93(5):E114-E117. doi: 10.1002/ajh.25055. Epub 2018 Feb 10.
5
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.罗道尔夫病中相互排斥的 KRAS 和 MAP2K1 突变。
Mod Pathol. 2017 Oct;30(10):1367-1377. doi: 10.1038/modpathol.2017.55. Epub 2017 Jun 30.
6
Histiocytoses: emerging neoplasia behind inflammation.组织细胞增多症：炎症背后的新兴肿瘤。
Lancet Oncol. 2017 Feb;18(2):e113-e125. doi: 10.1016/S1470-2045(17)30031-1.
7
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
8
Rosai-Dorfman disease of the genito-urinary tract: analysis of six cases from the testis and kidney.生殖道罗-道氏病：来自睾丸和肾脏的 6 例分析。
Histopathology. 2014 Dec;65(6):908-16. doi: 10.1111/his.12494. Epub 2014 Oct 30.
9
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.朗格汉斯细胞组织细胞增生症和 Erdheim-Chester 病与 BRAFV600E 突变相关。
Blood. 2014 Aug 14;124(7):1119-26. doi: 10.1182/blood-2013-12-543793. Epub 2014 Jun 3.
10
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.厄德里希-切斯特病诊断与临床管理的共识指南。
Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21.

Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by .

作者信息

Razanamahery Jérôme, Diamond Eli L, Cohen-Aubart Fleur, Plate Karl-Heinz, Lourida Giota, Charlotte Frederic, Hélias-Rodzewicz Zofia, Goyal Gaurav, Go Ronald S, Dogan Ahmet, Abdel-Wahab Omar, Durham Benjamin, Ozkaya Neval, Amoura Zahir, Emile Jean-Francois, Haroche Julien

机构信息

Internal Medicine Department 2, Assistance Publique-Hôpitaux de Paris, French National Reference Center for Histiocytoses, Pitié-Salpêtrière Hospital, Paris, France.

Paris VI University, UPMC, Sorbonne Universités, Paris, France.

出版信息

Haematologica. 2020 Jan;105(1):e5-e8. doi: 10.3324/haematol.2019.216937. Epub 2019 May 23.

DOI:10.3324/haematol.2019.216937
PMID:31123032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6939531/
Abstract
摘要